What is a disease? Perspectives of the public, health professionals and legislators

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Tikkinen, Kari A O ^a,b   Leinonen, Janne S ^c   Guyatt, Gordon H ^a   Ebrahim, Shanil ^a   Järvinen, Teppo L N ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Division of Insurance   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATIVE PERSONNEL; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DATA BASE; FINLAND; FIVE POINT LIKERT SCALE; HEALTH BEHAVIOR; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH LEGISLATOR; HEALTH SURVEY; HUMAN; LIKERT SCALE; NURSE; OUTCOME ASSESSMENT; PERCEPTION; PHYSICIAN; POPULATION BASED CASE CONTROL STUDY; PUBLIC HEALTH; TAX;

EID: 84872289424     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001632     Document Type: Article

References (53)

1. Eisenberg L. Disease and illness. Distinctions between professional and popular ideas of sickness. Cult Med Psychiatry 1977;1: 9-23.
2. Campbell EJ, Scadding JG, Roberts RS. The concept of disease. Br Med J 1979;2: 757-62. (Pubitemid 10231333)
3. Wulff HR. The concept of disease: from Newton back to Aristotle. Lancet 1999;354(Suppl):SIV50. (Pubitemid 30006739)
4. Temple LK, McLeod RS, Gallinger S, et al. Essays on science and society. Defining disease in the genomics era. Science 2001;293: 807-8. (Pubitemid 32743959)
5. Pearce JM. Disease, diagnosis or syndrome? Pract Neurol 2011;11: 91-7.
6. McWhinney IR. Health and disease: problems of definition. CMAJ 1987;136:815.
7. Seguin CA. The concept of disease. Psychosom Med 1946;8: 252-7.
8. Conrad P, Schneider JW. Deviance and medicalization: from badness to sickness. Philadelphia: Temple University Press, 1992.
9. Hinshaw SP, Cicchetti D. Stigma and mental disorder: conceptions of illness, public attitudes, personal disclosure, and social policy. Dev Psychopathol 2000;12: 555-98.
10. Perry BL. The labeling paradox: stigma, the sick role, and social networks in mental illness. J Health Soc Behav 2011;52: 460-77.
11. Smith R. In search of 'non-disease'. BMJ 2002;324: 883-5.
12. Heath I. Who needs health care - the well or the sick? BMJ 2005;330: 954-6.
13. Moynihan R. Medicalization. A new deal on disease definition. BMJ 2011;342:d2548.
14. Scully JL. What is a disease? EMBO Rep 2004;5: 650-3.
15. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002;324: 886-91.
16. Metzl JM, Herzig RM. Medicalisation in the 21st century: introduction. Lancet 2007;369: 697-8. (Pubitemid 46281315)
17. Kleinman A. Culture, bereavement, and psychiatry. Lancet 2012;379: 608-9.
18. Foucault M. The birth of the clinic: an archaeology of medical perception. New York: Pantheon Books, 1973.
19. Conrad P. Medicalization and social control. Annu Rev Sociol 1992;18: 209-32.
20. Padamsee TJ. The pharmaceutical corporation and the 'good work' of managing women's bodies. Soc Sci Med 2011;72: 1342-50.
21. Parsons T. The Social System. New York: The Free Press, 1951.
22. Shilling C. Culture, the 'sick role' and the consumption of health. Br J Sociol 2002;53: 621-38.
23. Parsons T. The sick role and the role of the physician reconsidered. Milbank Mem Fund Q Health Soc 1975;53: 257-78.
24. Meador CK. The art and science of nondisease. N Engl J Med 1965;272: 92-5.
25. International Statistical Classification of Diseases and Health Related Problems, version 10 (ICD-10). Geneva: World Health Organization. http://apps.who.int/classifications/icd10/browse/2010/ en (accessed 1 Feb 2012).
26. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 2007;335: 806-8. (Pubitemid 350057266)
27. Tversky A, Kahneman D. The framing of decisions and the psychology of choice. Science 1981;211: 453-8. (Pubitemid 11145313)
28. Gallagher KM, Updegraff JA. Health message framing effects on attitudes, intentions, and behavior: a meta-analytic review. Ann Behav Med 2012;43: 101-16.
29. Mishra S, Gregson M, Lalumière ML. Framing effects and risk-sensitive decision making. Br J Psychol 2012;103: 83-97.
30. Akl EA, Oxman AD, Herrin J, et al. Framing of health information messages. Cochrane Database Syst Rev 2011;CD006777.
31. Jones MP. What's a disease? Am J Gastroenterol 2003;98: 2813-14.
32. Tang CH, Liu JT, Chang CW, et al. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan. Health Policy 2007;82: 251-62.
33. Perry BL, Pescosolido BA, Martin JK, et al. Comparison of public attributions, attitudes, and stigma in regard to depression among children and adults. Psychiatr Serv 2007;58: 632-5. (Pubitemid 46841884)
34. Lund TB, Sandoe P, Lassen J. Attitudes to publicly funded obesity treatment and prevention. Obesity (Silver Spring) 2011;19: 1580-5.
35. Stronks K, Strijbis AM, Wendte JF, et al. Who should decide? Qualitative analysis of panel data from public, patients, healthcare professionals, and insurers on priorities in health care. BMJ 1997;315: 92-6. (Pubitemid 27285442)
36. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340: 1881-7. (Pubitemid 29272669)
37. Gillum LA, Gouveia C, Dorsey ER, et al. NIH disease funding levels and burden of disease. PLoS One 2011;6:e16837.
38. Hawkes N. NHS will soon have to specify what care is and what isn't freely available, GPs say. BMJ 2012;344:e1493.
39. Basson R, Berman J, Burnett A, et al. Report of the international consensus development conference on female sexual dysfunction: definitions and classifications. J Urol 2000;163: 888-93. (Pubitemid 30091640)
40. Gandey A. US slams Canada over Vancouver's new drug injection site. CMAJ 2003;169:1063.
41. Moynihan R. The making of a disease: female sexual dysfunction. BMJ 2003;326: 45-7. (Pubitemid 36110722)
42. Hyman SE. The neurobiology of addiction: implications for voluntary control of behavior. Am J Bioeth 2007;7: 8-11.
43. Madueme H. Addiction as an amoral condition? The case remains unproven. Am J Bioeth 2007;7: 25-7.
44. Levy N. The social: a missing term in the debate over addiction and voluntary control. Am J Bioeth 2007;7: 35-6.
45. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet 2007;369: 946-55. (Pubitemid 46400832)
46. Lancet editorial board. HIV and injecting drug use: a global call for action. Lancet 2011;377:1212.
47. Moscrop A. Medicalisation, morality, and addiction: why we should be wary of problem gamblers in primary care. Br J Gen Pract 2011;61:e836-8.
48. McNeil DG Jr. An H.I.V. strategy invites addicts in. The New York Times, 16 Sept 2011. http://www.nytimes.com/2011/02/08/health/ 08vancouver.html? pagewanted=all (accessed 1 Feb 2012).
49. Broom DH, Woodward RV. Medicalisation reconsidered: a collaborative approach to care. Sociol Health Illn 1996; 18: 357-78.
50. Wharton S, VanderLelie S, Sharma AM, et al. Feasibility of an interdisciplinary program for obesity management in Canada. Can Fam Physician 2012;58:e32-8.
51. Scadding JG. Essentialism and nominalism in medicine: logic of diagnosis in disease terminology. Lancet 1996;348: 594-6. (Pubitemid 26283895)
52. Tikkinen KA, Auvinen A. Does the imprecise definition of overactive bladder serve commercial rather than patient interests? Eur Urol 2012;61: 746-8.
53. King M, Bartlett A. British psychiatry and homosexuality. Br J Psychiatry 1999;175: 106-13. (Pubitemid 29359371)